Epiduo (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil DermaControl Moisturizer SPF 30, and Cetaphil DermaControl Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

Trial Profile

Epiduo (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil DermaControl Moisturizer SPF 30, and Cetaphil DermaControl Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Adapalene/benzoyl peroxide (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology.
    • 10 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top